✦ LIBER ✦
Significant dose Escalation of Idarubicin in the treatment of aggressive Non- Hodgkin Lymphoma leads to increased hematotoxicity without improvement in efficacy in comparison to standard CHOEP-14: 9-year follow up results of the CIVEP trial of the DSHNHL
✍ Scribed by Hohloch, Karin; Zwick, Carsten; Ziepert, Marita; Hasenclever, Dirk; Kaiser, Ulrich; Engert, Andreas; Höffkes, Heinz-Gert; Kroschinsky, Frank; Mesters, Rolf; Feller, Andreas C; Löffler, Markus; Trümper, Lorenz; Pfreundschuh, Michael
- Book ID
- 121573770
- Publisher
- Springer
- Year
- 2014
- Tongue
- English
- Weight
- 300 KB
- Volume
- 3
- Category
- Article
- ISSN
- 2193-1801
No coin nor oath required. For personal study only.